Vivo Bio Tech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

14.90

14.26

13.42

12.89

12.35

Share application money

-

0.69

1.43

-

0.30

Preference share capital

-

-

-

-

-

Reserves & surplus

36.97

32.19

27.70

20.15

14.63

Loan funds

Secured loans

60.17

65.24

28.73

22.09

21.67

Unsecured loans

-

-

-

-

-

Total

112.04

112.38

71.27

55.12

48.95

Uses of funds

Fixed assets

Gross block

122.53

122.38

74.31

53.66

48.32

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

37.02

30.57

25.62

22.04

18.50

Net block

85.51

91.81

48.69

31.63

29.82

Capital work-in-progress

1.90

0.87

0.32

0.15

0.07

Investments

0.04

0.04

0.04

0.04

0.03

Net current assets

Current assets, loans & advances

33.36

27.58

28.26

29.60

25.16

Less : current liabilities & provisions

8.76

7.91

6.04

6.30

6.12

Total net current assets

24.60

19.67

22.22

23.30

19.04

Miscellaneous expenses not written

-

-

-

-

-

Total

112.04

112.38

71.27

55.12

48.95

Notes:

Book value of unquoted investments

-

-

-

0.04

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

149.04

142.64

134.20

128.88

123.51